Cytisinicline could offer adult cigarette smokers a potential new treatment option

FHS
July 11, 2023
11:23 pm

The first large-scale U.S. clinical trial of cytisinicline, led by a Massachusetts General Hospital (MGH) investigator, found the smoking cessation medication to be effective and well tolerated in adults who wished to break their nicotine dependence.

Aurora Cannabis ACB stock Soars and why ACB stock will keep going up.

September 13, 2023

Screen time and autism, TikTok and birth control, fighting disinformation

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. Election Day is finally here. What to

November 5, 2024

Scientists uncover “genomic tug of war” that influences chemotherapy’s effectiveness

Some patients with myelodysplastic syndromes, like acute myeloid leukemia, benefit from a chemotherapy drug called decitabine that stunts cancer growth. But many others are resistant

November 17, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.